Results 31 to 40 of about 39,460 (147)

Oral Vancomycin, Ursodeoxycholic Acid, or No Therapy for Pediatric Primary Sclerosing Cholangitis: A Matched Analysis

open access: yesHepatology, 2020
Many children with primary sclerosing cholangitis (PSC) receive oral vancomycin therapy (OVT) or ursodeoxycholic acid (UDCA). There is a paucity of data on whether these medications improve outcomes.
M. Deneau   +33 more
semanticscholar   +1 more source

Prognostic value of thyroid hormone levels in patients evaluated for liver transplantation [PDF]

open access: yes, 1985
The thyroid hormones T4, T3, rT3 and TSH were assayed in 134 adult patients evaluated and accepted as potential liver transplant candidates at the Universty of Pittsburgh from March, 1981 to December, 1983.
Carter   +20 more
core   +1 more source

Pharmacological interventions for primary sclerosing cholangitis: an attempted network meta-analysis. [PDF]

open access: yes, 2017
BACKGROUND: Primary sclerosing cholangitis is a chronic cholestatic liver disease that is associated with both hepatobiliary and colorectal malignancies, which can result in liver cirrhosis and its complications. The optimal pharmacological treatment for
Davidson, Brian R   +6 more
core   +4 more sources

Fungi participate in the dysbiosis of gut microbiota in patients with primary sclerosing cholangitis

open access: yesGut, 2019
Objective Patients with primary sclerosing cholangitis (PSC) were previously shown to display a bacterial gut dysbiosis but fungal microbiota has never been examined in these patients.
S. Lemoinne   +8 more
semanticscholar   +1 more source

Role of the Microbiota and Antibiotics in Primary Sclerosing Cholangitis [PDF]

open access: yes, 2013
Primary sclerosing cholangitis (PSC) is an idiopathic, progressive, cholestatic liver disease with considerable morbidity and mortality and no established pharmacotherapy.
James H. Tabibian   +2 more
core   +2 more sources

Efficacy of hepatic transplantation in patients with primary sclerosing cholangitis [PDF]

open access: yes, 1993
Controlled trials to assess the therapeutic benefit of orthotopic hepatic transplantation (OHTx) for primary sclerosing cholangitis (PSC) cannot be justified in view of improvement of patient survival after this operation since 1981.
Abu-Elmagd, KM   +9 more
core  

Primary sclerosing cholangitis: a pre-malignant condition [PDF]

open access: yes, 2017
Primary sclerosing cholangitis (PSC) is a chronic, progressive, cholestatic liver disease with no known cure. It is a serious condition, and diagnosis comes with an increased risk of developing cancer of the gallbladder, bile ducts or liver. Symptoms can
Mortimore, Gerri
core   +2 more sources

Cholangiocarcinoma in sclerosing cholangitis. The role of liver transplantation [PDF]

open access: yes, 1989
Our experience with patients who underwent orthotopic liver transplantation for sclerosing cholangitis at the University of Pittsburgh Health Center between March 1980 and March 1988 is reported here.
Iwatsuki, S   +3 more
core  

Survival after liver transplantation in the United Kingdom and Ireland compared with the United States

open access: yes, 2007
<b>Background and Aim</b>: Surgical mortality in the US is widely perceived to be superior to that in the UK. However, previous comparisons of surgical outcome in the two countries have often failed to take sufficient account of case-mix or ...
Copley, L.P.   +4 more
core   +2 more sources

Tacrolimus (FK 506), a Treatment for Primary Sclerosing Cholangitis: Results of an Open‐Label Preliminary Trial [PDF]

open access: yes, 1995
Primary sclerosing cholangitis (PSC) is a chronic inflammatory disease of the liver that is characterized by progressive cholestasis and the development of secondary biliary cirrhosis. There is no widely recognized therapy for this disease, although anti‐
Abu‐Elmagd, K   +6 more
core   +1 more source

Home - About - Disclaimer - Privacy